Evaluation of Advance Directives Use and Impact on Adult ICU Patients at University Hospital Basel from 2011 to 2023
Led by University Hospital, Basel, Switzerland · Updated on 2026-06-17
2000
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to better understand how advance directives are used and implemented in the intensive care unit ICU and how they affect patient outcomes. The study focuses on adult patients treated in the ICU at the University Hospital Basel between 2011 and 2023. It compares outcomes such as survival, neurological function recovery, and Glasgow Outcome Score between patients with and without advance directives.
The study involves collecting health-related personal data from digital medical records of all eligible adult ICU patients during the specified period. Extracted data include patient characteristics, hospitalization details, presence and content of advance directives, clinical information, treatments received, and outcomes at discharge. This observational study does not involve administering any treatment but analyzes existing data retrospectively.
Participants involvement is limited to data collection from their medical records. Researchers will analyze the proportion of patients with advance directives and how these directives are applied in clinical practice. Outcomes measured include survival rates, neurological recovery, and Glasgow Outcome Scores at hospital discharge. The study covers data from 2011 through 2023, with the study completion expected by December 2050.
CONDITIONS
Brief Title
Advance Directive Implementation and Scientific Evaluation Study
Research Team
R
Raoul Sutter, PD Dr. med
S
Sira Baumann, Cand. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adult patients treated for more than 48 hours in the intensive care unit (post-operative or internal medicine) of the University Hospital Basel between 2011 and 2023
You will not qualify if you...
Patients with documented refusal of general consent
Patients treated in the intensive care unit for less than 48 hours
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
null
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Prevalence, clinical impact and associated patient-centred outcomes of advance directives in Swiss intensive care units: Results from the retrospective ADVISE Study.
Sira Maria Baumann, Dominik Vock, Paulina S C Kliem...